1 Key Insights

2 Report Introduction

3 Wilson's disease Epidemiology Overview at a Glance

3.1 Patient Share (%) Distribution of Wilson's disease in 2018
3.2 Patient Share (%) Distribution of Wilson's disease in 2030

4 Executive Summary of Wilson's disease

5 Disease Background and Overview

5.1 Introduction
5.2 Symptoms
5.3 Etiology
5.4 Clinical Manifestation
5.5 Copper Metabolism
5.6 Pathogenesis
5.7 Diagnosis

6 Epidemiology and Patient Population

6.1 Key Findings
6.2 7MM Total Prevalent Patient Population of Wilson's disease
6.3 Epidemiology of Wilson's disease
6.4 The United States
6.4.1 Prevalent Cases of Wilson's disease in the United States
6.4.2 Diagnosed Prevalent Cases of Wilson's disease in the United States
6.4.3 Prevalent cases of Wilson's disease based on Clinical Manifestation in the US
6.5 EU5
6.5.1 Germany
6.5.2 France
6.5.3 Italy
6.5.4 Spain
6.5.5 United Kingdom
6.6 Japan
6.6.1 Prevalent Cases of Wilson's disease in Japan
6.6.2 Diagnosed Prevalent Cases of Wilson's disease in Japan
6.6.3 Prevalent cases of Wilson's disease based on Clinical Manifestation in Japan

7 Treatment of Wilson's disease

8 Organizations contributing towards Wilson's disease

9 Patient Journey

10 Case Reports

11 KOL Views

12 Appendix

12.1 Bibliography
12.2 Report Methodology

13 DelveInsight Capabilities

14 Disclaimer

15 About DelveInsight

List of Tables
Table 1: Summary of Wilson's disease Epidemiology, and Key Events (2018-2030)
Table 2: Prevalent Patient Population of Wilson's disease in the7MM (2018-2030)
Table 3: Prevalent Cases of Wilson's disease in the United States (2018-2030)
Table 4: Diagnosed Prevalent Cases of Wilson's disease in the United States (2018-2030)
Table 5: Prevalent cases of Wilson's Disease based on Clinical Manifestation in the US (2018-2030)
Table 6: Prevalent Cases of Wilson's disease in Germany (2018-2030)
Table 7: Diagnosed Prevalent Cases of Wilson's disease in Germany (2018-2030)
Table 8: Prevalent cases of Wilson's Disease based on Clinical Manifestation in Germany (2018-2030)
Table 9: Prevalent Cases of Wilson's disease in France (2018-2030)
Table 10: Diagnosed Prevalent Cases of Wilson's disease in France (2018-2030)
Table 11: Prevalent cases of Wilson's Disease based on Clinical Manifestation in France (2018-2030)
Table 12: Prevalent Cases of Wilson's disease in Italy (2018-2030)
Table 13: Diagnosed Prevalent Cases of Wilson's disease in Italy (2018-2030)
Table 14: Prevalent cases of Wilson's Disease based on Clinical Manifestation in Italy (2018-2030)
Table 15: Prevalent Cases of Wilson's disease in Spain (2018-2030)
Table 16: Diagnosed Prevalent Cases of Wilson's disease in Spain (2018-2030)
Table 17: Prevalent cases of Wilson's Disease based on Clinical Manifestation in Spain (2018-2030)
Table 18: Prevalent Cases of Wilson's disease in the United Kingdom (2018-2030)
Table 19: Diagnosed Prevalent Cases of Wilson's disease in the United Kingdom (2018-2030)
Table 20: Prevalent cases of Wilson's Disease based on Clinical Manifestation in the UK (2018-2030)
Table 21: Prevalent Cases of Wilson's disease in Japan (2018-2030)
Table 22: Diagnosed Prevalent Cases of Wilson's disease in Japan (2018-2030)
Table 23: Prevalent cases of Wilson's Disease based on Clinical Manifestation in Japan (2018-2030)
Table 24: Organizations contributing towards Wilson's Disease

List of Figures
Figure 1: Illustration of the proteins and pathways critical for hepatocyte copper metabolism.
Figure 2: Structural model of Wilson's disease copper-transporting ATPase, ATP7b, illustrating adenosine triphosphate (ATP)-dependent copper transport across the lipid bilayer.
Figure 3: Copper toxicity in the pathogenesis of WD
Figure 4: Diagnostic algorithms for Wilson's disease based on the Leipzig Score
Figure 5: Prevalent Population of Wilson's disease in the 7MM (2018-2030)
Figure 6: Prevalent Cases of Wilson's disease in the United States (2018-2030)
Figure 7: Diagnosed Prevalent Cases of Wilson's disease in the United States (2018-2030)
Figure 8: Prevalent cases of Wilson's Disease based on Clinical Manifestation in the US (2018-2030)
Figure 9: Prevalent Cases of Wilson's disease in Germany (2018-2030)
Figure 10: Diagnosed Prevalent Cases of Wilson's disease in Germany (2018-2030)
Figure 11: Prevalent cases of Wilson's Disease based on Clinical Manifestation in Germany (2018-2030)
Figure 12: Prevalent Cases of Wilson's disease in France (2018-2030)
Figure 13: Diagnosed Prevalent Cases of Wilson's disease in France (2018-2030)
Figure 14: Prevalent cases of Wilson's Disease based on Clinical Manifestation in France (2018-2030)
Figure 15: Prevalent Cases of Wilson's disease in Italy (2018-2030)
Figure 16: Diagnosed Prevalent Cases of Wilson's disease in Italy (2018-2030)
Figure 17: Prevalent cases of Wilson's Disease based on Clinical Manifestation in Italy (2018-2030)
Figure 18: Prevalent Cases of Wilson's disease in Spain (2018-2030)
Figure 19: Diagnosed Prevalent Cases of Wilson's disease in Spain (2018-2030)
Figure 20: Prevalent cases of Wilson's Disease based on Clinical Manifestation in Spain (2018-2030)
Figure 21: Prevalent Cases of Wilson's disease in the United Kingdom (2018-2030)
Figure 22: Diagnosed Prevalent Cases of Wilson's disease in the United Kingdom (2018-2030)
Figure 23: Prevalent cases of Wilson's Disease based on Clinical Manifestation in the UK (2018-2030)
Figure 24: Prevalent Cases of Wilson's disease in Japan (2018-2030)
Figure 25: Diagnosed Prevalent Cases of Wilson's disease in Japan (2018-2030)
Figure 26: Prevalent cases of Wilson's Disease based on Clinical Manifestation in Japan (2018-2030)